earnings
MX
NASDAQ · MXCT
MaxCyte, Inc.
Healthcare · Medical - Devices
$1.29
Up+$0.07 (+5.74%)
Updated Sep 1, 2026, 11:10 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 170.68M
- P/E ratio
- -3.73
- Dividend yield
- 0.00%
- 52-week range
- $0.64 – $1.87
- Volume
- 777.28K
- Avg. volume
- 961.6K
Price performance
MXCT price history
1M range · 21 trading sessions · Daily adjusted prices
MXCT closed at $1.29 after 21 trading sessions, up 20.56% for the selected period.
- Last close
- $1.29
- Period change
- +20.56%
- Period low
- $1.07
- Period high
- $1.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $1.19 | $1.315 | $1.19 | $1.29 | 777.28K |
| Aug 28, 2026 | $1.30 | $1.30 | $1.21 | $1.22 | 563.72K |
| Aug 27, 2026 | $1.31 | $1.325 | $1.28 | $1.28 | 360.77K |
| Aug 26, 2026 | $1.35 | $1.35 | $1.31 | $1.31 | 292.3K |
| Aug 25, 2026 | $1.38 | $1.39 | $1.34 | $1.35 | 310.49K |
| Aug 24, 2026 | $1.36 | $1.40 | $1.35 | $1.39 | 620.49K |
| Aug 21, 2026 | $1.40 | $1.40 | $1.355 | $1.38 | 435.91K |
| Aug 20, 2026 | $1.39 | $1.405 | $1.36 | $1.38 | 611.85K |
| Aug 19, 2026 | $1.29 | $1.40 | $1.2705 | $1.39 | 948.46K |
| Aug 18, 2026 | $1.30 | $1.31 | $1.26 | $1.27 | 443.7K |
| Aug 17, 2026 | $1.32 | $1.39 | $1.295 | $1.32 | 703.26K |
| Aug 14, 2026 | $1.39 | $1.407 | $1.27 | $1.32 | 1M |
| Aug 13, 2026 | $1.17 | $1.54 | $1.16 | $1.39 | 3.8M |
| Aug 12, 2026 | $1.36 | $1.36 | $1.22 | $1.27 | 1.96M |
| Aug 11, 2026 | $1.22 | $1.26 | $1.20 | $1.24 | 745.95K |
| Aug 10, 2026 | $1.17 | $1.225 | $1.16 | $1.21 | 925.56K |
| Aug 7, 2026 | $1.12 | $1.18 | $1.12 | $1.18 | 464.48K |
| Aug 6, 2026 | $1.08 | $1.14 | $1.08 | $1.11 | 861.65K |
| Aug 5, 2026 | $1.11 | $1.12 | $1.07 | $1.07 | 496.89K |
| Aug 4, 2026 | $1.07 | $1.13 | $1.07 | $1.11 | 319.76K |
| Aug 3, 2026 | $1.06 | $1.095 | $1.05 | $1.07 | 374.63K |
Latest MXCT news
The latest Smart Investors Daily articles mentioning MXCT.
Stock researchCompany · Financials
Loading stock research…